Analysts’ Viewpoint on Thyroid Function Test Market Scenario
The global thyroid function test market is primarily driven by the increase in geriatric population, rise in health care spending per household, and improvement in health care infrastructure. According to the World Health Organization (WHO), approximately 750 million people across the globe are suffering from some form of thyroid disorder. Thyroid disorders occur primarily in women as compared to men. Thyroid function tests are vital for the diagnosis of hypo- or hyperthyroidism. According to the Journal of Clinical Endocrinology and Metabolism, hypothyroidism accounts for 30% to 40% of the total thyroid disorders diagnosed. Market players are focusing on increasing their R&D investments to launch innovative and technologically advanced test procedures in the global market.
Thyroid function test, or thyroid test, checks the levels of hormones that are produced by the thyroid gland as well as the pituitary gland situated in the brain. The accuracy of thyroid test results could be affected by medication including vitamin supplements or herbal remedies. Therefore, these tests must be performed under the recommendation and guidance of a doctor.
Request a sample to get extensive insights into the Thyroid Function Test Market
Alcohol consumption is considered one of the high-risk factors for disease and disability. Globally, high-income countries in developed regions account for the highest alcohol consumption, with around 50.1% of the U.S. population (adults over 18 years of age) being regular drinkers. As per various studies, there exists a negative relationship between the hypothalamic-pituitary-thyroid (HPT) axis and alcoholism. Regular drinking inhibits peripheral thyroid hormones, frees T3 and T4, and minimizes the activity of type II 5’-deiodinase, which further affects metabolic function. This leads to the development of hypothyroidism. Tobacco also induces changes in thyroid function tests such as a decrease in TSH levels and increase in thyroid hormones.
A shortage of endocrinologists is expected to restrain the thyroid function testing market. Currently, fewer than 6,500 endocrinologists are available in the U.S. to offer care for millions of patients suffering from thyroid disease, diabetes, osteoporosis, and other hormonal conditions. Difficulty associated with the interpretation of thyroid blood tests is another factor contributing to the sluggish growth of the thyroid function test market. Treatment of thyroid gland disorders includes surgery, anti-thyroid drugs (methimazole and propylthiouracil), and radioactive iodine. Thyroid cancer diagnostics involve blood tests, physical exams, and ultrasound imaging. Hypothyroidism disorder treatment entails daily usage of the synthetic thyroid hormone levothyroxine (Levo-T, Synthroid, and others).
The global thyroid function test market is primarily driven by the increase in incidence of thyroid disorders such as hypothyroidism and hyperthyroidism. According to the Endocrine Society, around 140 hypothyroidism and 10 hyperthyroidism cases are reported among every 1,000 individuals in the U.S. each year. The number of patients affected by autoimmune diseases such as Grave’s disease is increasing across the globe.
The World Health Organization (WHO) and the American Association of Clinical Endocrinologists (AACE) have stated that thyroid disorders are rapidly increasing, and they demand novel and effective thyroid therapeutics for treatment. According to the WHO, thyroid disorders such as hypothyroidism, hyperthyroidism, and goiter are common conditions affecting millions of people globally. As per the Journal of Clinical Endocrinology and Metabolism, thyroid dysfunction (i.e. hypothyroidism) is the leading endocrine disorder, and accounts for around 30% to 40% of the total endocrine patients. Thus, demand for thyroid function tests such as TSH, T3, and T4 has been rising across the globe.
Request a custom report on Thyroid Function Test Market
In terms of revenue, the TSH test segment held major share of the global market in 2021. The segment is anticipated to account for around 53% share of the global market by 2031. TSH test facilitates cost-effective disease screening and introduces novel definitions of subclinical hypothyroidism or hyperthyroidism, along with delivering biochemical treatment targets. TSH test measures the level of thyroid-stimulating hormone in the patient’s blood.
The TSH test does not explain why TSH levels are too low or too high. If the test results are abnormal, the health care provider generally orders additional tests to gauge the cause of the thyroid problem. These tests include T3 thyroid hormone tests, T4 thyroid hormone tests, tests for diagnosing Graves' disease (an autoimmune disease that causes hyperthyroidism), or tests to diagnose Hashimoto's thyroiditis (an autoimmune disease that causes hypothyroidism). TSH remains the most sensitive parameter for primary dysthyroid conditions, while free thyroid hormone levels (FT4, FT3) are useful adjuncts for the refinement of diagnosis (pituitary dysthyroid conditions) and monitoring of therapy.
The hospital-based laboratories segment led the global thyroid function test market in 2021. The segment is anticipated to account for around 50% share of the global market by 2031. The hospital-based laboratories segment is expected to grow at a CAGR of 5.5% from 2022 to 2031. Patients prefer hospital-based laboratories, as they offer benefits such as free online counseling and guidance for thyroid function tests. These factors are likely to drive the hospital-based laboratories segment.
The diagnostic laboratories segment is projected to account for large share of the market during the forecast period due to the increase in adoption of advanced technologies across these establishments. According to a recent study, TFT algorithms could be deployed in diagnostic laboratories without compromising therapeutic accuracy. This would help in the reduction of direct costs and also protect patients from the consequences of low-value care practices.
North America dominated the global thyroid function test market in 2021. The market in the region is anticipated to grow at a CAGR of 5.5% from 2022 to 2031. North America is likely to lead the thyroid function test market due to the increasing prevalence of thyroid cancer in the U.S. The National Cancer Institute has estimated around 43,800 new cases of thyroid cancer (11,860 in men and 31,940 in women) and about 2,230 deaths from thyroid cancer (1,070 men and 1,160 women) in 2022. The market in North America is also likely to grow due to several U.S. Government initiatives such as the compulsory screening of newborns for congenital hypothyroidism, revolutionary research work on thyroid hormone function, cost-effective methods to detect thyroid cancer, and promising research on Graves’ disease. Increase in approval for various tests and treatments by regulatory bodies in the region is also expected to drive the market.
Asia Pacific is a highly attractive region of the market owing to the rise in incidence of diseases and investment by key players in the region. The market in Middle East & Africa is expanding at a sluggish pace due to slow economic growth, low awareness, and low per capita income of the people in the region.
The thyroid function test market report concludes with the company profiles section, which includes information about key players operating in the global market. Leading players analyzed in the report include Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Abbott Laboratories, DiaSorin S.p.A., Danaher Corporation, Siemens Healthineers, Merck KGaA, bioMérieux SA, Qualigen Inc., and Autobio Diagnostics Co., Ltd.
Each of these players has been profiled in the thyroid function test market report based on parameters such as company overview, financial overview, business strategies, application portfolio, business segments, and recent developments.
Attribute |
Detail |
Market Size Value in 2021 |
US$ 1.5 Bn |
Market Forecast Value in 2031 |
More than US$ 2.6 Bn |
Growth Rate |
CAGR of 5.4% from Year-to-Year |
Forecast Period |
2022–2031 |
Historical Data Available for |
2017–2021 |
Quantitative Units |
US$ Bn for Value |
Market Analysis |
It includes cross segment analysis at global as well as regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
Competition Landscape |
|
Format |
Electronic (PDF) + Excel |
Market Segmentation |
|
Regions Covered |
|
Countries Covered |
|
Companies Profiled |
|
Customization Scope |
Available upon request |
Pricing |
Available upon request |
The global thyroid function test market was valued at US$ 1.5 Bn in 2021
The global thyroid function test market is projected to reach US$ 2.6 Bn by 2031
Increase in cases of thyroid disorders, rise in awareness about thyroid disorders, surge in prevalence of lifestyle diseases, rise in geriatric population, and increase in consumption of alcohol and tobacco are key factors impacting the market
North America is expected to account for major share of the global market during the forecast period
The TSH test segment is anticipated to account for 53% share of the global market by 2031
Prominent players in the global thyroid function test market include Thermo Fisher, F. Hoffmann-La Roche Ltd, Abbott Laboratories, and Danaher Corporation
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology
3. Executive Summary: Global Thyroid Function Test Market
4. Market Overview
4.1. Introduction (Product Definition)
4.2. Drivers
4.2.1. Increasing Incidence of Thyroid Gland Disorders
4.2.2. Rise in Obese, Diabetic, and Cardiovascular Patients
4.2.3. Growing Disease Awareness Programs in Developing Regions
4.2.4. Developing Countries Reshaping Global Health and Development
4.3. Restraints
4.3.1. Asymptomatic Nature of Thyroid Disorders Lead to Large Undiagnosed Population
4.4. Opportunities
4.4.1. Expand Footprint in Emerging Nations That Offer Sustained Growth Opportunities
5. Market Outlook
5.1. Global Thyroid Gland Disorders (Hypothyroidism and Hyperthyroidism) Epidemiology
5.2. Age and Gender Specific Prevalence Cases for Thyroid Disorders
5.3. Key Industry Developments
6. Global Thyroid Function Test Market Analysis and Forecast, by Type
6.1. Key Findings
6.2. Introduction
6.3. Global Thyroid Function Test Market Value (US$ Bn) Forecast, by Type
6.3.1. TSH Test
6.3.2. T4 Test
6.3.3. T3 Test
6.3.4. Others
6.4. Global Thyroid Function Test Market Attractiveness, by Type
7. Global Thyroid Function Test Market Analysis, by End-user
7.1. Key Findings
7.2. Introduction
7.3. Global Thyroid Function Test Market Value (US$ Bn) Forecast, by End-user
7.3.1. Hospital-based Laboratories
7.3.2. Diagnostic Laboratories
7.3.3. Research Institutes
7.3.4. Others
7.4. Global Thyroid Function Test Market Attractiveness, by End-user
8. Global Thyroid Function Test Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Introduction
8.3. Global Thyroid Function Test Market Value (US$ Bn) Forecast, by Region
8.3.1. North America
8.3.2. Europe
8.3.3. Asia Pacific
8.3.4. Latin America
8.3.5. Middle East & Africa
9. North America Thyroid Function Test Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. North America Thyroid Function Test Market Forecast, by Type
9.2.1. TSH Test
9.2.2. T4 Test
9.2.3. T3 Test
9.2.4. Others
9.3. North America Thyroid Function Test Market Forecast, by End-user
9.3.1. Hospital-based Laboratories
9.3.2. Diagnostic Laboratories
9.3.3. Research Institutes
9.3.4. Others
9.4. North America Thyroid Function Test Market Forecast, by Country
9.4.1. U.S. Thyroid Function Test Market Overview
9.4.2. Canada Thyroid Function Test Market Overview
9.5. North America Thyroid Function Test Market Attractiveness Analysis, by Type
9.6. North America Thyroid Function Test Market Attractiveness Analysis, by End-user
9.7. North America Thyroid Function Test Market Attractiveness Analysis, by Country
10. Europe Thyroid Function Test Market Analysis and Forecast
10.1. Key Findings
10.2. Europe Thyroid Function Test Market Forecast, by Type
10.2.1. TSH Test
10.2.2. T4 Test
10.2.3. T3 Test
10.2.4. Others
10.3. Europe Thyroid Function Test Market Forecast, by End-user
10.3.1. Hospital-based Laboratories
10.3.2. Diagnostic Laboratories
10.3.3. Research Institutes
10.3.4. Others
10.4. Europe Thyroid Function Test Market Forecast, by Country/Sub-region
10.4.1. Germany Thyroid Function Test Market Overview
10.4.2. France Thyroid Function Test Market Overview
10.4.3. U.K. Thyroid Function Test Market Overview
10.4.4. Spain Thyroid Function Test Market Overview
10.4.5. Italy Thyroid Function Test Market Overview
10.4.6. Rest of Europe Thyroid Function Test Market Overview
10.5. Europe Thyroid Function Test Market Attractiveness Analysis, by Type
10.6. Europe Thyroid Function Test Market Attractiveness Analysis, by End-user
10.7. Europe Thyroid Function Test Market Attractiveness Analysis, by Country/Sub-region
11. Asia Pacific Thyroid Function Test Market Analysis and Forecast
11.1. Key Findings
11.2. Asia Pacific Thyroid Function Test Market Forecast, by Type
11.2.1. TSH Test
11.2.2. T4 Test
11.2.3. T3 Test
11.2.4. Others
11.3. Asia Pacific Thyroid Function Test Market Forecast, by End-user
11.3.1. Hospital-based Laboratories
11.3.2. Diagnostic Laboratories
11.3.3. Research Institutes
11.3.4. Others
11.4. Asia Pacific Thyroid Function Test Market Forecast, by Country/Sub-region
11.4.1. China Thyroid Function Test Market Overview
11.4.2. Japan Thyroid Function Test Market Overview
11.4.3. Australia & New Zealand Thyroid Function Test Market Overview
11.4.4. Rest of Asia Pacific Thyroid Function Test Market Overview
11.5. Asia Pacific Thyroid Function Test Market Attractiveness Analysis, by Type
11.6. Asia Pacific Thyroid Function Test Market Attractiveness Analysis, by End-user
11.7. Asia Pacific Thyroid Function Test Market Attractiveness Analysis, by Country/Sub-region
12. Latin America Thyroid Function Test Market Analysis and Forecast
12.1. Key Findings
12.2. Latin America Thyroid Function Test Market Forecast, by Type
12.2.1. TSH Test
12.2.2. T4 Test
12.2.3. T3 Test
12.2.4. Others
12.3. Latin America Thyroid Function Test Market Forecast, by End-user
12.3.1. Hospital-based Laboratories
12.3.2. Diagnostic Laboratories
12.3.3. Research Institutes
12.3.4. Others
12.4. Latin America Thyroid Function Test Market Forecast, by Country/Sub-region
12.4.1. Brazil Thyroid Function Test Market Overview
12.4.2. Mexico Thyroid Function Test Market Overview
12.4.3. Rest of Latin America Thyroid Function Test Market Overview
12.5. Latin America Thyroid Function Test Market Attractiveness Analysis, by Type
12.6. Latin America Thyroid Function Test Market Attractiveness Analysis, by End-user
12.7. Latin America Thyroid Function Test Market Attractiveness Analysis, by Country/Sub-region
13. Middle East & Africa Thyroid Function Test Market Analysis and Forecast
13.1. Key Findings
13.2. Middle East & Africa Thyroid Function Test Market Forecast, by Type
13.2.1. TSH Test
13.2.2. T4 Test
13.2.3. T3 Test
13.2.4. Others
13.3. Middle East & Africa Thyroid Function Test Market Forecast, by End-user
13.3.1. Hospital-based Laboratories
13.3.2. Diagnostic Laboratories
13.3.3. Research Institutes
13.3.4. Others
13.4. Middle East & Africa Thyroid Function Test Market Forecast, by Country/Sub-region
13.4.1. GCC Countries Thyroid Function Test Market Overview
13.4.2. South Africa Thyroid Function Test Market Overview
13.4.3. Rest of Middle East & Africa Thyroid Function Test Market Overview
13.5. Middle East & Africa Thyroid Function Test Market Attractiveness Analysis, by Type
13.6. Middle East & Africa Thyroid Function Test Market Attractiveness Analysis, by End-user
13.7. Middle East & Africa Thyroid Function Test Market Attractiveness Analysis, by Country/Sub-region
14. Competition Landscape
14.1. Global Thyroid Function Test Market Share Analysis, by Company
14.2. Company Profiles
14.2.1. Thermo Fisher Scientific Inc.
14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.1.2. Financial Overview
14.2.1.3. Product Portfolio
14.2.1.4. SWOT Analysis
14.2.1.5. Strategic Overview
14.2.2. F. Hoffmann-La Roche Ltd
14.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.2.2. Financial Overview
14.2.2.3. Product Portfolio
14.2.2.4. SWOT Analysis
14.2.2.5. Strategic Overview
14.2.3. Abbott Laboratories
14.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.3.2. Financial Overview
14.2.3.3. Product Portfolio
14.2.3.4. SWOT Analysis
14.2.3.5. Strategic Overview
14.2.4. DiaSorin S.p.A.
14.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.4.2. Financial Overview
14.2.4.3. Product Portfolio
14.2.4.4. SWOT Analysis
14.2.4.5. Strategic Overview
14.2.5. Danaher Corporation
14.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.5.2. Financial Overview
14.2.5.3. Product Portfolio
14.2.5.4. SWOT Analysis
14.2.5.5. Strategic Overview
14.2.6. Siemens Healthineers
14.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.6.2. Financial Overview
14.2.6.3. Product Portfolio
14.2.6.4. SWOT Analysis
14.2.6.5. Strategic Overview
14.2.7. Merck KGaA
14.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.7.2. Product Portfolio
14.2.7.3. SWOT Analysis
14.2.7.4. Strategic Overview
14.2.8. bioMérieux SA
14.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.8.2. Financial Overview
14.2.8.3. Product Portfolio
14.2.8.4. SWOT Analysis
14.2.8.5. Strategic Overview
14.2.9. Qualigen Inc.
14.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.9.2. Financial Overview
14.2.9.3. Product Portfolio
14.2.9.4. SWOT Analysis
14.2.9.5. Strategic Overview
14.2.10. Autobio Diagnostics Co., Ltd.
14.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.10.2. Financial Overview
14.2.10.3. Product Portfolio
14.2.10.4. SWOT Analysis
14.2.10.5. Strategic Overview
List of Tables
Table 01: Global Thyroid Function Test Market Value (US$ Bn) Forecast, by Type, 2017–2021
Table 02: Global Thyroid Function Test Market Value (US$ Bn) Forecast, by End-user, 2017–2021
Table 03: Global Thyroid Function Test Market Value (US$ Bn) Forecast, by Region, 2017–2021
Table 04: North America Thyroid Function Test Market Value (US$ Bn) Forecast, by Country, 2017–2021
Table 05: North America Thyroid Function Test Market Value (US$ Bn) Forecast, by Type, 2017–2021
Table 06: North America Thyroid Function Test Market Value (US$ Bn) Forecast, by End-user, 2017–2021
Table 07: Europe Thyroid Function Test Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2021
Table 08: Europe Thyroid Function Test Market Value (US$ Bn) Forecast, by Type, 2017–2021
Table 09: Europe Thyroid Function Test Market Value (US$ Bn) Forecast, by End-user, 2017–2021
Table 10: Asia Pacific thyroid function test Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2021
Table 11: Asia Pacific Thyroid Function Test Market Value (US$ Bn) Forecast, by Type, 2017–2021
Table 12: Asia Pacific Thyroid Function Test Market Value (US$ Bn) Forecast, by End-user, 2017–2021
Table 13: Latin America Thyroid Function Test Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2021
Table 14: Latin America Thyroid Function Test Market Value (US$ Bn) Forecast, by Type, 2017–2021
Table 15: Latin America Thyroid Function Test Market Value (US$ Bn) Forecast, by End-user, 2017–2021
Table 16: Middle East & Africa Thyroid Function Test Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2021
Table 17: Middle East & Africa Thyroid Function Test Market Value (US$ Bn) Forecast, by Type, 2017–2021
Table 18: Middle East & Africa Thyroid Function Test Market Value (US$ Bn) Forecast, by End-user, 2017–2021
Table 19: Thermo Fisher Scientific, Inc., Recent Developments
Table 20: F. Hoffmann-La Roche AG, Recent Developments
Table 21: DiaSorin S.p.A., Recent Developments
Table 22: Merck KGaA, Recent Developments
Table 23: bioMérieux SA, Recent Developments
List of Figures
Figure 01: Global Thyroid Function Test Market Value (US$ Bn) and Distribution, by Region, 2021 and 2027
Figure 02: Market Snapshot of Global Thyroid Function Test Market
Figure 03: Global Thyroid Function Test Market Value (US$ Bn) Forecast, 2017–2021
Figure 04: Global Thyroid Function Test Market Value Share, by Type, 2021
Figure 05: Global Thyroid Function Test Market Value Share, by End-user, 2021
Figure 06: Global Thyroid Function Test Market Value Share, by Region, 2021
Figure 07: Global Thyroid Function Test Market Value Share Analysis, by Type, 2021 and 2027
Figure 08: Global Thyroid Function Test Market Attractiveness, by Type, 2017–2021
Figure 09: Global Thyroid Function Test Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by TSH Test, 2017–2021
Figure 10: Global Thyroid Function Test Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by T4 Test, 2017–2021
Figure 11: Global Thyroid Function Test Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by T3 Test, 2017–2021
Figure 12: Global Thyroid Function Test Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017–2021
Figure 13: Global Thyroid Function Test Market Value Share Analysis, by End-user, 2017 and 2026
Figure 14: Global Thyroid Function Test Market Attractiveness, by End-user, 2021–2026
Figure 15: Global Thyroid Function Test Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Hospital-based Laboratories, 2017–2021
Figure 16: Global Thyroid Function Test Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Diagnostic Laboratories, 2017–2021
Figure 17: Global Thyroid Function Test Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Research Institutes, 2017–2021
Figure 18: Global Thyroid Function Test Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017–2021
Figure 19: Global Thyroid Function Test Market Value Share (%), by Region, 2021 and 2027
Figure 20: Global Thyroid Function Test Market Attractiveness, by Region, 2017–2021
Figure 21: North America Thyroid Function Test Market Value (US$ Bn) Forecast, 2017–2021
Figure 22: North America Thyroid Function Test Market Value Share (%), by Country, 2021 and 2027
Figure 23: North America Thyroid Function Test Market Attractiveness, by Country, 2017–2021
Figure 24: North America Thyroid Function Test Market Value Share (%), by Type, 2021 and 2027
Figure 25: North America Thyroid Function Test Market Attractiveness, by Type, 2017–2021
Figure 26: North America Thyroid Function Test Market Value Share (%), by End-user, 2021 and 2027
Figure 27: North America Thyroid Function Test Market Attractiveness, by End-user, 2017–2021
Figure 28: Europe Thyroid Function Test Market Value (US$ Bn) Forecast, 2017–2021
Figure 29: Europe Thyroid Function Test Market Value Share (%), by Country/Sub-region, 2021 and 2027
Figure 30: Europe Thyroid Function Test Market Attractiveness, by Country/Sub-region, 2017–2021
Figure 31: Europe Thyroid Function Test Market Value Share (%), by Type, 2021 and 2027
Figure 32: Europe Thyroid Function Test Market Attractiveness, by Type, 2017–2021
Figure 33: Europe Thyroid Function Test Market Value Share (%), by End-user, 2021 and 2027
Figure 34: Europe Thyroid Function Test Market Attractiveness, by End-user, 2017–2021
Figure 35: Asia Pacific Thyroid Function Test Market Value (US$ Bn) Forecast, 2017–2021
Figure 36: Asia Pacific Thyroid Function Test Market Value Share (%), by Country/Sub-region, 2021 and 2027
Figure 37: Asia Pacific Thyroid Function Test Market Attractiveness, by Country/Sub-region, 2017–2021
Figure 38: Asia Pacific Thyroid Function Test Market Value Share (%), by Type, 2021 and 2027
Figure 39: Asia Pacific Thyroid Function Test Market Attractiveness, by Type, 2017–2021
Figure 40: Asia Pacific Thyroid Function Test Market Value Share (%), by End-user, 2021 and 2027
Figure 41: Asia Pacific Thyroid Function Test Market Attractiveness, by End-user, 2017–2021
Figure 42: Latin America Thyroid Function Test Market Value (US$ Bn) Forecast, 2017–2021
Figure 43: Latin America Thyroid Function Test Market Value Share (%), by Country/Sub-region, 2021 and 2027
Figure 44: Latin America Thyroid Function Test Market Attractiveness, by Country/Sub-region, 2017–2021
Figure 45: Latin America Thyroid Function Test Market Value Share (%), by Type, 2021 and 2027
Figure 46: Latin America Thyroid Function Test Market Attractiveness, by Type, 2017–2021
Figure 47: Latin America Thyroid Function Test Market Value Share (%), by End-user, 2021 and 2027
Figure 48: Latin America Thyroid Function Test Market Attractiveness, by End-user, 2017–2021
Figure 49: Middle East & Africa Thyroid Function Test Market Value (US$ Bn) Forecast, 2017–2021
Figure 50: Middle East & Africa Thyroid Function Test Market Value Share (%), by Country/Sub-region, 2017 and 2026
Figure 51: Middle East & Africa Thyroid Function Test Market Attractiveness, by Country/Sub-region, 2021–2026
Figure 52: Middle East & Africa Thyroid Function Test Market Value Share (%), by Type, 2021 and 2027
Figure 53: Middle East & Africa Thyroid Function Test Market Attractiveness, by Type, 2017–2021
Figure 54: Middle East & Africa Thyroid Function Test Market Value Share (%), by End-user, 2021 and 2027
Figure 55: Middle East & Africa Thyroid Function Test Market Attractiveness, by End-user, 2017–2021
Figure 56: Global Thyroid Function Test Market Share, by Company, 2021
Figure 57: Thermo Fisher Scientific, Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2017–2021
Figure 58: Thermo Fisher Scientific, Inc. Breakdown of Net Sales, by Region, 2021
Figure 59: Thermo Fisher Scientific, Inc. Breakdown of Net Sales, by Business Segment, 2021
Figure 60: Abbott Laboratories Revenue (US$ Bn) & Y-o-Y Growth (%), 2017–2031
Figure 61: Abbott Laboratories Breakdown of Net Sales, by Region, 2021
Figure 62: Abbott Laboratories Breakdown of Net Sales, by Segment, 2021
Figure 63: F. Hoffmann-La Roche AG Breakdown of Net Sales, by Business Division, 2021
Figure 64: F. Hoffmann-La Roche AG Revenue (US$ Bn) and Y-o-Y Growth (%), 2017–2031
Figure 65: F. Hoffmann-La Roche AG Breakdown of Net Sales (Pharmaceutical Segment), by Country/Region, 2021
Figure 66: DiaSorin S.p.A. Breakdown of Net Sales, by Region, 2017
Figure 67: DiaSorin S.p.A. Revenue (US$ Bn) & Y-o-Y Growth (%), 2017–2021
Figure 68: DiaSorin S.p.A. Breakdown of Net Sales, by Segment, 2017
Figure 69: Danaher Corporation Breakdown of Net Sales, by Region, 2021
Figure 70: Danaher Corporation Revenue (US$ Bn) & Y-o-Y Growth (%), 2017–2031
Figure 71: Danaher Corporation Breakdown of Net Sales, by Segment, 2021
Figure 72: Siemens Healthineers Revenue (US$ Bn) and Y-o-Y Growth (%), 2017–2031
Figure 73: Siemens Healthineers Diagnostics Business Segment, Breakdown of Net Sales (%), by Region, 2021
Figure 74: Siemens Healthineers Diagnostics Business Segment, Breakdown of Net Sales (%), by Business Segment, 2021
Figure 75: Merck KGaA Breakdown of Net Sales, by Region, 2021
Figure 76: Merck KGaA Revenue (US$ Bn) & Y-o-Y Growth (%), 2017–2031
Figure 77: Merck KGaA Breakdown of Net Sales, by Segment, 2021
Figure 78: bioMérieux SA Revenue (US$ Bn) & Y-o-Y Growth (%), 2017–2031
Figure 79: bioMérieux SA Breakdown of Net Sales, by Region, 2021
Figure 80: bioMérieux SA Breakdown of Net Sales, by Segment, 2021